Navigation Links
Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition

NEW YORK, July 15, 2014 /PRNewswire-iReach/ -- Venture Planning Group (, an international publishing and management consulting firm, is pleased to introduce "Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition," a series of new global surveys designed to identify major business opportunities emerging in the diagnostics market during the next five years.  The reports examine key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; review over 400 current and emerging assays; analyze potential applications of innovative diagnostic technologies; forecast volume and sales by assay, market segment, and country; provide test volume estimates by method; profile leading players and potential market entrants; and suggest alternative business expansion strategies for suppliers.

To review these new reports, please visit

- Winning Strategies in Molecular Diagnostics 
Integrating New Technology Planning with Business and Corporate Strategies
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

- Infectious Disease Testing:  Rapidly Growing and Challenging Market Facing Suppliers
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

- Cancer Diagnostics:  Market on the Verge of Explosion
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence    

- Immunodiagnostics: Spot Fast-Growing Market Segments
Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

- Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges
Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market

- Coagulation Testing in Transition
Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside

- 2014 Molecular Blood Typing, Grouping and Infectious Disease NAT Market
France, Germany, Italy, Japan, Spain, UK, US--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

These thought-provoking reports are designed to provide the in vitro diagnostics industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs.

The studies offer expert analyses, strategic insights and granular data, such as supplier shares and sales forecasts for over 400 diagnostic tests by country and market segment.

The reports are available by region, country, section, market segment, individual test, and can be custom-tailored to specific information needs and budget.

The global diagnostic market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances will radically change the global diagnostics market during the next five years.  New specific and sensitive markers will be increasingly used on automated instrumentation.  Diagnostic testing will also become more standardized, offering opportunities for quality control products and services.  Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the diagnostic testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

To review these and related IVD reports, please visit

For further details or questions regarding these reports, please contact:

Robert Fisher 
+1 212 564 2838

Media Contact: Robert Fisher, Venture Planning Group, 212-564-2838,

News distributed by PR Newswire iReach:

SOURCE Venture Planning Group
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. QBC Diagnostics Awarded GSA Contract
2. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
3. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
4. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
5. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics
6. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
7. Breakthrough Prostate Cancer Diagnostics
8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
11. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19
Post Your Comments:
(Date:11/25/2015)... Endo International plc (NASDAQ: ENDP ) (TSX: ... and CEO, will discuss corporate updates at the 27 th ... York on Wednesday, December 2, 2015 at 1 ... Relations, and then the link to the event. Participants should ... to visit the site and download any streaming media software ...
(Date:11/25/2015)... Asia -based venture ... and the New Investors will make a direct equity ... private placement. The financing will help IOPtima to continue ... in the treatment of glaucoma, as well as to ... system with the U.S. Food and Drug Administration, commencing ...
(Date:11/25/2015)... PHILADELPHIA, Pennsylvania , November 25, 2015 ... Continuing Medical Education (CME) --> ... Care Continuing Medical Education (CME) ... -of- Care Continuing Medical Education (CME) ... and medical information products and services, will feature latest diagnostic imaging ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., ... the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by ... through Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part ... For Empowerment ™ attracts volunteers together who want to combine talents and resources ... key stakeholders in the process. The non-profit launched its first major fundraiser on ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, a Jacksonville-based drug ... their sobriety and show through pictures what a positive difference it makes. The ... with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short ...
(Date:11/25/2015)... ... 25, 2015 , ... On November 23rd 2015 Cozy Products, a ... products business. Cozy Products explains what this means for business moving forward. , The ... Cozy Products business model: to sell personal heaters that reduce energy consumption, are economical ...
Breaking Medicine News(10 mins):